Tracking Residual Risk: Time for a Change?
- PMID: 33736828
- DOI: 10.1016/j.jacc.2021.01.035
Tracking Residual Risk: Time for a Change?
Keywords: LDL cholesterol; apolipoprotein B; mortality; myocardial infarction; non-HDL cholesterol; statin treatment.
Conflict of interest statement
Funding Support And Author Disclosures Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.J Am Coll Cardiol. 2021 Mar 23;77(11):1439-1450. doi: 10.1016/j.jacc.2021.01.027. J Am Coll Cardiol. 2021. PMID: 33736827
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical